4//SEC Filing
AUXILIUM PHARMACEUTICALS INC 4
Accession 0001209191-14-071389
CIK 0001182129operating
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 10:55 AM ET
Size
14.0 KB
Accession
0001209191-14-071389
Insider Transaction Report
Form 4
JOBES ELIZABETH VARKI
Chief Compliance Officer
Transactions
- Exercise/Conversion
Common Stock
2014-11-25$17.68/sh+20,000$353,600→ 37,819 total - Sale
Common Stock
2014-11-25$34.05/sh−4,052$137,964→ 37,517 total - Exercise/Conversion
Nonqualified Stock Option (Right to Buy)
2014-11-25−20,000→ 20,000 totalExercise: $17.68From: 2013-05-07Exp: 2022-05-07→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2014-11-25$18.30/sh+3,750$68,625→ 41,569 total - Sale
Common Stock
2014-11-25$34.03/sh−23,750$808,310→ 13,767 total - Exercise/Conversion
Nonqualified Stock Option (Right to Buy)
2014-11-25−3,750→ 11,250 totalExercise: $18.30From: 2014-02-07Exp: 2023-02-07→ Common Stock (3,750 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.01 to $34.095, inclusive.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.015 to $34.095, inclusive.
Documents
Issuer
AUXILIUM PHARMACEUTICALS INC
CIK 0001182129
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001182129
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 10:55 AM ET
- Size
- 14.0 KB